Noonan Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials

Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome
Conditions:   Genetic Disorder;   Noonan SyndromeIntervention:   Drug: somatropinSponsor:   Novo Nordisk A/SActive, not recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2013 Category: Research Source Type: clinical trials

Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome
Conditions:   Genetic Disorder;   Noonan SyndromeIntervention:   Drug: somatropinSponsor:   Novo Nordisk A/SActive, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 20, 2013 Category: Research Source Type: clinical trials

Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome
Conditions:   Genetic Disorder;   Noonan SyndromeIntervention:   Drug: somatropinSponsor:   Novo Nordisk A/SRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 20, 2013 Category: Research Source Type: clinical trials

Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome
Conditions:   Genetic Disorder;   Noonan SyndromeIntervention:   Drug: somatropinSponsor:   Novo Nordisk A/SActive, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 20, 2013 Category: Research Source Type: clinical trials

Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome
Conditions:   Genetic Disorder;   Noonan SyndromeIntervention:   Drug: somatropinSponsor:   Novo Nordisk A/SActive, not recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 20, 2013 Category: Research Source Type: clinical trials